ZNTL

SEC filing ZNTL Presents Phase 1b MUIR Trial Data Showing 39% ORR, 7.3-Month Median PFS for Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer

11d ago

News Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News

14d ago

News Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold

14d ago

SEC filing ZNTL Reports $12B Revenue, $3.4B Net Income, Announces $20B Buyback

28d ago

SEC filing ZNTL Announces $1.2B Oncology Deal, $45M Cash, +30% Pipeline Growth, 2026 FDA Approval Target

54d ago

Insider trade Sale by Julia Marie Eastland (CEO & President)

104d ago

Insider trade Sale by Vincent Vultaggio (PAO and PFO)

104d ago

Insider trade Sale by Ingmar Bruns (Chief Medical Officer)

104d ago

Insider trade Sale by Vincent Vultaggio (PAO and PFO)

104d ago

News Indonesia CDS Widen Most in Months After Moody’s Lowers Outlook - Bloomberg.com

116d ago

News National Bank Holdings outlines 10% loan growth and $4 EPS target for 2027 as Vista integration advances

124d ago

Scanner Unusual volume (z=11.3)

165d ago

News Incyclix Bio Expands Board of Directors with Appointment of Dr. Kimberly Blackwell

165d ago

SEC filing ZNTL Repurchases 7.5M Shares from Matrix Capital at $1.33, Board Member Resigns

168d ago